Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.
about
The treatment of late-onset hypogonadismMild cognitive impairment and dementia: the importance of modifiable risk factorsTestosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Association of testosterone levels with socio-demographic characteristics in a sample of Ugandan menTestosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and EDThe association of time of day and serum testosterone concentration in a large screening population.Could androgens maintain specific domains of mental health in aging men by preserving hippocampal neurogenesis?Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach.Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men.Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic reviewTestosterone and men's quality of life.Which patients with sexual dysfunction are suitable for testosterone replacement therapy?The aging male--diagnosis and therapy of late-onset hypogonadism.Androgens and male aging: Current evidence of safety and efficacy.Recent topics related to testosterone deficiency syndrome in Japan.Male sexual dysfunction in Asia.Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice.The Relationship between Testosterone Deficiency and Men's HealthISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.Erectile function and late-onset hypogonadism symptoms related to lower urinary tract symptom severity in elderly men.Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.Do androgens play any role in the physical frailty of ageing men?Late onset hypogonadism, sexuality and fertility.Androgens, health and sexuality in women and men.Treatment strategies for diabetic patients suffering from erectile dysfunction: an update.Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management.Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.Serum levels of hypothalamic-pituitary-testicular axis hormones in men with or without prostate cancer or atypical small acinar proliferation.Transplanted human p75-positive stem Leydig cells replace disrupted Leydig cells for testosterone production.Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires.Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report.Laboratory diagnosis of late-onset male hypogonadism andropause.The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.The aging males' symptoms scale for Japanese men: reliability and applicability of the Japanese version.Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?Importance of Different Grades of Abdominal Obesity on Testosterone Level, Erectile Dysfunction, and Clinical Coincidence.
P2860
Q26795519-2DC929C1-D10E-40E4-B34C-BAE3B6B5CB37Q26994975-926505DA-199B-40DB-956B-1423D97B7477Q33276072-12876C34-A3AE-43C3-B91B-EA48CE58D24DQ34097510-7E09D985-21BE-44DE-9F4F-51CA99367C5AQ34335660-37AF1C94-B7D6-40FF-8B44-7A5A98B7FD6AQ34485718-8C4DE028-2A8E-45ED-B182-44F35FA02B89Q34635438-2D7217D0-38F5-4D55-A2DD-2AF78976E5ACQ34720192-0F8DAE4B-DE91-4057-ADF5-E9A880D498E6Q34884322-54553E91-2177-4C09-A7EE-4F4BC4C7C2E0Q36155429-CC530256-0791-4EF7-91F7-5328A2667A7DQ36207705-2E4A1F3C-48F9-4C4C-ACF0-F85E39D22EFFQ36687893-D733D24D-F6C9-48D7-B883-184929851E9DQ37030456-DF741F15-BADD-4EBC-B74B-DEA0E49BF955Q37064524-5F4D3DA2-3F5D-451A-AE59-561941A3FDC1Q37084126-AF6F71D5-B0D7-42FA-BDF2-8F0D054A53E8Q37085390-E7391BA5-3484-417F-BCB7-A010EBDFD64EQ37085395-D51D0C52-5540-435A-ACDF-78EF420560BEQ37113194-0BB33F99-5B18-4C5E-A208-7C76CA11AA7DQ37165023-553F8C15-FCD5-4D49-8211-DB1582BEC49DQ37299250-2FF6D3A7-57F4-4DBE-AC54-D335B5B3999DQ37310024-1D1D0B90-BFA4-4FB6-A416-5C539784F348Q37370480-FAD40FEC-32F8-4B9B-8F59-A8C8FAA0C09CQ37378541-5EA3609D-84ED-40F2-AA42-91F5B4094F84Q37781089-EBAEAD7E-DB57-4E95-ABB1-F28EA40E8F98Q37789736-434B43D0-37A6-43A2-B30A-C8319D37CB10Q37813672-8D0CD1C2-BA98-4046-937F-13D887DF33C0Q38224353-83DCA4DD-B783-453C-82E2-08F7A2B376D6Q38572877-8B698E49-C1AA-4DBA-9ECC-373B9D9DF1ACQ39422921-9B115452-2693-4F27-814A-B8612F395891Q40998389-C0231A41-EBAF-47EC-BC29-8307C9AE15E1Q42133690-0AA83B6E-33AF-42D5-A309-2FCCAA56E0A9Q43942025-B6041603-3A36-42DB-937D-A2DC1D0F5AC3Q44790679-8E26FE17-7E87-4B4E-B243-83B3F4707FD2Q44832085-019B6CEA-F1E7-4F16-86B4-5BDC034DE80DQ46116814-18891405-461A-49C1-B066-71A2F6F51726Q46131362-30AB6A5C-B9F5-48E4-829A-C50321F4DB9CQ46343590-3B9D82D5-9DB0-4222-8A18-0A7FA3E8D56FQ46544719-39F99182-F040-4C24-AC2D-A8A04BA1CDC6Q46596427-1BA08ED9-10C5-4066-A701-FBAF74E29D85Q47097279-277A9A48-2A77-4CCD-AE4C-8D933723D5E7
P2860
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@en
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@nl
type
label
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@en
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@nl
prefLabel
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@en
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@nl
P2093
P1433
P1476
Investigation, treatment and m ...... SSAM, and EAU recommendations.
@en
P2093
B Lunenfeld
C Schulman
E Nieschlag
European Association of Urology (EAU)
International Society for the Study of the Aging Male (ISSAM)
International Society of Andrology (ISA)
J E Morley
P356
10.1016/J.EURURO.2005.04.027
P407
P577
2005-07-01T00:00:00Z